Sera Prognostics (NASDAQ:SERA) executives emphasized progress in evidence generation and early commercialization efforts ...

As we shared last year, to support Sera Prognostics, Inc.'s next phase of commercialization, we strengthened our leadership ...

The company targets active discussions in 15–17 states and aims to run 5–7 partner programs by the end of 2026, representing 58–60% of U.S. births. Aerts explained, "We have budgeted the same -- ...

Alerted by prognostics to a problem with a component or part, a fleet may not choose to take a risk on it performing another 20,000 miles before regularly scheduled truck maintenance. “Because it’s 50 ...

Sera Prognostics Inc. Annual stock financials by MarketWatch. View the latest SERA financial statements, income statements and financial ratios.

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Sera Prognostics ( ...

Sera Prognostics is a women's health company that develops innovative diagnostic tests aimed at improving the health of mothers and babies. The company's flagship product, PreTRM, is a blood test that ...

"Following the results of our full PRIME pivotal study being publicized we are leveraging them by engaging with key plan providers in focused geographic regions hard hit by premature birth," said ...

DALLAS. Prognostics – being able to predict a component or part failure in advance – will be the true growth area in telematics in the coming decade, at least in North America and Europe, a leading ...